Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Radical Alkylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Ag-catalyzed cyanoalkylation method solves photocatalysis scale-up issues. Delivers high-purity pharmaceutical intermediates with cost-effective manufacturing.
Patent CN115353497A reveals a metal-free photocatalytic route for beta-C benzothiazole ethers, offering cost reduction and simplified purification for pharmaceutical intermediate manufacturing.
Patent CN111138315B reveals a scalable Ag-catalyzed route for cyanoalkyl quinones, replacing costly photocatalysis for efficient pharmaceutical intermediate manufacturing.
Patent CN114380741B details a green Ag-catalyzed method for 4-alkylated quinolines. Achieves high purity and yield in water, offering significant cost reduction in API manufacturing.
Patent CN111116465B reveals Ag-catalyzed cyanoalkylation. Efficient route for drug intermediates with scalable conditions.
Patent CN120398774A enables high-yield, mild-condition synthesis of C-3 alkylated quinoxalinones, offering scalable routes with simplified purification for pharmaceutical supply chains.